¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå : ¹ÙÀÌ¿À¸¶Ä¿ À¯Çüº°, ¾Ï À¯Çüº°, ÇÁ·ÎÆÄÀϸµ ±â¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°
Cancer Biomarkers Market, By Biomarker Type, By Cancer Type, By Profiling Technology, By End User, By Geography
»óǰÄÚµå : 1672664
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº 2025³â¿¡ 289¾ï ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 676¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â CAGRÀº 12.9%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 289¾ï ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR: 12.90% 2032³â °¡Ä¡ ¿¹Ãø 676¾ï 2,000¸¸ ´Þ·¯
µµÇ¥. 2025³â Áö¿ªº° ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå Á¡À¯À²(%)
Cancer Biomarkers Market-IMG1

¾Ï ¹ÙÀÌ¿À¸¶Ä¿´Â Ç÷¾×, Á¶Á÷ ¹× ±âŸ ü¾×¿¡¼­ ¹ß°ßµÇ´Â »ý¹°ÇÐÀû ºÐÀÚ·Î, Á¤»ó ¶Ç´Â ºñÁ¤»óÀûÀÎ °úÁ¤À̳ª »óÅ ¶Ç´Â Áúº´ÀÇ Â¡ÈÄÀÔ´Ï´Ù. À̵éÀº ¾ÏÀ̳ª ¾ÏÀÇ ÁøÇàÀ» °¨ÁöÇϰųª ¸ð´ÏÅ͸µÇÏ´Â µ¥ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖ±Ù ¾Ï ¹ÙÀÌ¿À¸¶Ä¿´Â ¾ÏÀÇ Áø´Ü, º´±â ºÐ·ù, ÃßÀû¿¡ ´ëÇÑ ÃÖ¼Ò Ä§½ÀÀû Á¢±ÙÀÌ °¡´ÉÇϹǷΠÀü ¼¼°è °ø°ø ±â°ü ¹× ¹Î°£ ´Üü¿¡¼­ Å« °ü½ÉÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ¹ÙÀÌ¿À¸¶Ä¿¸¦ Ȱ¿ëÇÏ¸é ¾Ï Àü¹®ÀǴ ȯÀÚ °³°³ÀÎÀÇ ¾Ï ÇÁ·ÎÆÄÀÏ¿¡ µû¶ó ¸ÂÃãÇü Ä¡·á¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯ÀüÀÚ ÇÁ·ÎÆÄÀϸµ°ú ÇÏÀ̽º·çDz ±â¼úÀÇ ¹ßÀüÀº Ä¡·á ¹ÝÀÀ°ú º´ÀÇ ÁøÇàÀ» º¸´Ù Á¤È®ÇÏ°Ô ¿¹ÃøÇÒ ¼ö ÀÖ´Â ¹ÙÀÌ¿À¸¶Ä¿ÀÇ °¡´É¼ºÀ» ¿­¾îÁÖ¾ú½À´Ï´Ù. ÀÌ´Â Àü ¼¼°è ¾Ï Ä¡·áÀÇ °³¼±¿¡ À¯¸ÁÇÑ Àǹ̸¦ °¡Áö°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº Àü ¼¼°è ¾Ï ¹ßº´·ü Áõ°¡, Á¤¹ÐÀÇ·á ¹× µ¿¹ÝÁø´ÜÀÇ Àαâ Áõ°¡, ÀǾàǰ °³¹ß ¹× ½ÂÀο¡ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ È°¿ë È®´ë µîÀÔ´Ï´Ù. ±×·¯³ª ¹ÙÀÌ¿À¸¶Ä¿ÀÇ Å½»ö, °ËÁõ ¹× »ó¾÷È­¿¡ µû¸¥ ³ôÀº ºñ¿ëÀÌ ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼úÀû Á¦¾à ¹× »óȯ ºÎÁ·À¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¾Ï Àα¸°¡ ¸¹°í ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϰí ÀÖ´Â ½ÅÈï ±¹°¡¿¡¼­ À¯¸®ÇÑ »ç¾÷ ±âȸ¸¦ È®ÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸ Ȱµ¿À» ÅëÇØ ƯÈ÷ Ä¡·á°¡ ¾î·Á¿î ¾Ï¿¡ ´ëÇÑ »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿°¡ ¹ß°ßµÇ¸é ´õ ¸¹Àº ºñÁî´Ï½º ±âȸ°¡ âÃâµÉ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀåÀÇ Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, ¹ÙÀÌ¿À¸¶Ä¿ À¯Çüº°, 2020-2032³â, (10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, ¾Ï À¯Çüº°, 2020-2032³â, (10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2020-2032³â, (10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2020-2032³â, (10¾ï ´Þ·¯)

Á¦9Àå ¼¼°èÀÇ ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå, Áö¿ªº°, 2020-2032³â, (10¾ï ´Þ·¯)

  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹

    Á¦10Àå °æÀï ±¸µµ

    • bioMerieux, Inc.
    • INOVIQ
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • Becton, Dickinson and Company
    • Merck KGaA
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • CENTOGENE N.V.
    • PerkinElmer Inc.
    • Siemens Healthineers
    • F. Hoffmann-la Roche Ltd
    • Agilent Technologies, Inc
    • Invitae Corporation
    • Myriad Genetics
    • Guardant Health
    • Illumina
    • FOUNDATION MEDICINE, INC.

    Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ ½ÃÁ¡

    • ¿î¸íÀÇ ¼ö·¹¹ÙÄû
    • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
    • COM(Coherent Opportunity Map)

    Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

    • Âü°í ¹®Çå
    • Á¶»ç ¹æ¹ý
    KSA
  • ¿µ¹® ¸ñÂ÷

    ¿µ¹®¸ñÂ÷

    Global Cancer Biomarkers Market is estimated to be valued at USD 28.90 Bn in 2025 and is expected to reach USD 67.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2032.

    Report Coverage Report Details
    Base Year: 2024 Market Size in 2025: USD 28.90 Bn
    Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
    Forecast Period 2025 to 2032 CAGR: 12.90% 2032 Value Projection: USD 67.62 Bn
    Figure. Cancer Biomarkers Market Share (%), By Region 2025
    Cancer Biomarkers Market - IMG1

    Cancer biomarkers are biological molecules found in blood, tissues or other body fluids that are sign of a normal or abnormal process, or of a condition or disease. These can be used to detect and monitor cancer or cancer progression. In recent years, cancer biomarkers have gained significant attention from both global public and private organizations as these present minimally invasive ways to diagnose, stage and track cancer. Their use also enables oncologists to personalize treatments based on individual patient's cancer profiles. Advancements in genetic profiling and high-throughput technologies have unlocked the potential of biomarkers that can predict treatment responses and disease progression more accurately. This has promising implications for improving cancer care globally.

    Market Dynamics:

    Global cancer biomarkers market growth is driven by rising cancer prevalence worldwide, increasing popularity of precision medicine and companion diagnostics, and growing use of biomarkers in drug development as well as approvals. However, high costs associated with biomarker discovery, validation, and commercialization pose a challenge. Moreover, technical limitations and lack of reimbursements restrain the market growth. The market witnesses lucrative opportunities from emerging economies with large cancer populations and growing health expenditures. Further opportunities lie in discovery of novel biomarkers especially for hard-to-treat cancers through ongoing research efforts.

    Key Features of the Study:

    Detailed Segmentation-

    Table of Contents

    1. Research Objectives and Assumptions

    2. Market Purview

    3. Market Dynamics, Regulations, and Trends Analysis

    4. Global Cancer Biomarkers Market- Impact of Coronavirus (COVID-19) Pandemic

    5. Global Cancer Biomarkers Market, By Biomarker Type, 2020 - 2032, (USD BN)

    6. Global Cancer Biomarkers Market, By Cancer Type, 2020 - 2032, (USD BN)

    7. Global Cancer Biomarkers Market, By End User, 2020 - 2032, (USD BN)

    8. Global Cancer Biomarkers Market, By End User, 2020 - 2032, (USD BN)

    9. Global Cancer Biomarkers Market, By Region, 2020 - 2032, (USD BN)

    10. Competitive Landscape

    11. Analyst View

    12. References and Research Methodology

    (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
    ¨Ï Copyright Global Information, Inc. All rights reserved.
    PC¹öÀü º¸±â